A randomized controlled pilot trial of "feiji Recipe" on quality of life of non-small cell lung cancer patients

American Journal of Chinese Medicine

Volumn 38, Issue 1, 2010, Pages 15-25

  Tian, Jian Hui ^a   Liu, Ling Shuang ^a   Shi, Zhi Ming ^a   Zhou, Zhi Yi ^a   Wang, Lin ^b  

^a Department of Oncology   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Feiji Recipe; Quality of Life; TCM Therapy

Indexed keywords

CHINESE DRUG; CISPLATIN; FEIJI RECIPE; GEMCITABINE; NAVELBINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FEIJI; HERBACEOUS AGENT; VINBLASTINE;

ABSENCE OF SIDE EFFECTS; ADULT; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EMOTION; FATIGUE; FEMALE; HUMAN; INTESTINAL DYSMOTILITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; UNIVERSITY HOSPITAL; VOMITING; ADJUVANT CHEMOTHERAPY; ADOLESCENT; AGED; HEALTH SURVEY; LUNG TUMOR; MEDICINAL PLANT; METHODOLOGY; MIDDLE AGED; PHYTOTHERAPY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; DRUGS, CHINESE HERBAL; HEALTH SURVEYS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANTS, MEDICINAL; QUALITY OF LIFE; QUESTIONNAIRES; VINBLASTINE; YOUNG ADULT;

EID: 77951226480     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X10007646     Document Type: Article

References (34)

1. Aaronson, N.K., S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N.J. Duez, A. Filiberti, H. Flechtner, S.B. Fleishman and J.C. de Haes. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85: 365-376, 1993.
2. Armstrong, T., M.Z. Cohen, K.R. Hess, R. Manning, E.L. Lee, G. Tamayo, K. Baumgartner, S.J. Min, A. Yung and M. Gilbert. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J. Pain Symptom Manag. 32: 148-154, 2006.
3. Brown, J., H. Thorpe, V. Napp, D.J. Fairlamb, N.H. Gower, R. Milroy, M.K. Parmar, R.M. Rudd, S.G. Spiro, R.J. Stephens, D. Waller, P. West and M.D. Peake. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J. Clin. Oncol. 23: 7417-7427, 2005.
4. Bunn, P.A., Jr. and N. Thatcher. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Intro. Oncol. 13(Suppl. 1): 1-4, 2008.
5. Chen, X.P., Y.P. Zhang and X.R. Zhu. Clinical study on effects of tiepi fengdou granule/capsule combined with chemotherapy and/or radiotherapy in treating lung cancer with Qi-Yin asthenia syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 394-397, 2006.
6. Downs, T.M., M. Schultzel, H. Shi, C. Sanders, Z. Tahir and G.R. Sadler. Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients. Crit. Rev. Oncol./Hematol. 70: 59-70, 2009.
7. Earle, C.C. Outcomes research in lung cancer. J. Natl. Cancer Inst. Monogr. 33: 56-77, 2004.
8. Efficace, F., P.F. Innominato, G. Bjarnason, C. Coens, Y. Humblet, S. Tumolo, D. Genet, M. Tampellini, A. Bottomley, C. Garufi, C. Focan, S. Giacchetti and F. Levi. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. J. Clin. Oncol. 26: 2020-2026, 2008.
9. Grilli, R., A.D. Oxman and J.A. Julian. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J. Clin. Oncol. 11: 1866-1872, 1993.
10. Guo, L.L. and J. Wang. Discuss of efficacy study to traditional Chinese medicine complex prescription. Zhongguo Zhong Yao Za Zhi 33: 851-853, 2008.
11. Hirsch, F.R., W.A. Franklin, A.F. Gazdar and P.A. Bunn, Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res. 7(1): 5-22, 2001.
12. Hong, M.Y., N.P. Seeram, Y. Zhang and D. Heber. Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression. J. Med. Food 11: 657-666, 2008.
13. Huang, Y.S. and Z.M. Shi. Intervention effect of feiji recipe on immune escape of lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 27: 501-504, 2007.
14. Jiang, J., X. Liang, X. Zhou and R. Huang. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer 57: 348-358, 2007.
15. Johnson, J.R., G. Williams and R. Pazdur. End points and United States Food and Drug Administration approval of oncology drugs. J. Clin. Oncol. 21: 1404-1411, 2003.
16. Kimman, M.L., A.C. Voogd, C.D. Dirksen, P. Falger, P. Hupperets, K. Keymeulen, M. Hebly, C. Dehing, P. Lambin and L.J. Boersma. Improving the quality and efficiency of follow-up after curative treatment for breast cancer-rationale and study design of the MaCare trial. BMC Cancer 7: 1, 2007.
17. Konkimalla, V.B. and T. Efferth. Evidence-based Chinese medicine for cancer therapy. J. Ethnophar-macol. 116: 207-210, 2008.
18. Leung, K.S., Z.X. Bian, D. Moher, S. Dagenais, Y.P. Li, L. Liu, T.X. Wu and J.X. Miao. Improving the quality of randomized controlled trials in Chinese herbal medicine, part III: quality control of Chinese herbal medicine used in randomized controlled trials. Zhong Xi Yi Jie He Xue Bao 4: 225-232, 2006. (Pubitemid 43772770)
19. Li, J.H. A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 16: 136-138, 1996.
20. Lipscomb, J., C.C. Gotay and C.F. Snyder. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J. Clin. 57: 278-300, 2007.
21. Liu, J., Z. Shi, Z. Xu, Y. Zhu, L. Zhao, H. Li, H. Gao and S. Chen. Clinical observation on treatment of non-parvicellular carcinoma of the lung with jin fu kang oral liquid. J. Tradit. Chin. Med. 20: 96-100, 2000.
22. Molina, J.R., P. Yang, S.D. Cassivi, S.E. Schild and A.A. Adjei. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83: 584-594, 2008.
23. Parkin, D.M. Global cancer statistics in the year 2000. Lancet Oncol. 2: 533-543, 2001.
24. Ramalingam, S. and C. Belani. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 13: 5-13, 2008.
25. Sadava, D., J. Ahn, M. Zhan, M.L. Pang, J. Ding and S. Kane. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Chemother. Pharmacol. 49: 261-266, 2002.
26. Shang, A., K. Huwiler, L. Nartey, P. Juni and M. Egger. Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study. Int. J. Epidemiol. 36: 1086-1092, 2007. (Pubitemid 350019239)
27. Tamburini, M. Health-related quality of life measures in cancer. Ann. Oncol. 12: S7-10, 2001.
28. Tanvetyanon, T., H.P. Soares, B. Djulbegovic, P.B. Jacobsen and G.A. Bepler. Systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer. J. Thorac. Oncol. 2: 1091-1097, 2007.
29. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 91: 66-72, 1999.
30. Tian, J.H., Z.M. Shi, Z.Y. Zhou, Y.S. Huang and L. Wang. Effects of Feiji Formula on lung cancer metastasis in mice. Zhong Xi Yi Jie He Xue Bao 6: 827-829, 2008.
31. Wang, L., G.B. Zhou, P. Liu, J.H. Song, Y. Liang, X.J. Yan, F. Xu, B.S. Wang, J.H. Mao, Z.X. Shen, S.J. Chen and Z. Chen. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 105: 4826-4831, 2008.
32. Xu, M., G. Wang, H. Xie, Q. Huang, W. Wang and Y. Jia. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. J. Ethnopharmacol. 115: 483-488, 2008.
33. You, J., Z.M. Shi and B.H. Han. Evaluation on effect of feiji recipe on quality of life of patients with non-small cell lung cancer by adopting international questionnaire of QOL. Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 33-37, 2006.
34. Zhang, T. Effect of TCM therapy for removing toxic substance and unblocking meridians on postradiation quality of life in 55 patients with lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 28: 154-157, 2008.